Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti-trypanosomal 3-(oxazolo[4,5-b]pyridine-2-yl)anilide

RT @metabolomics: #Pharmacometabolomics reveals perturbation of sphingolipid metabolism by a novel anti-trypanosomal OXPA https://t.co/38U8…

RT @metabolomics: #Pharmacometabolomics reveals perturbation of sphingolipid metabolism by a novel anti-trypanosomal OXPA https://t.co/38U8…

RT @metabolomics: #Pharmacometabolomics reveals perturbation of sphingolipid metabolism by a novel anti-trypanosomal OXPA https://t.co/38U8…

#Pharmacometabolomics reveals perturbation of sphingolipid metabolism by a novel anti-trypanosomal OXPA https://t.co/38U8uv828G

A paradigm study for this type of research, a good path to follow.. https://t.co/1WYSODdT9E

#Lipid profiling reveals perturbation of sphingolipid metabolism by a novel anti-trypanosomal drug https://t.co/x7rFfTUwpq (@SpringerLink)

RT @CreekLab: From a phenotypic screen hit to mode of action- metabolomics and lipidomics bridge the gap. New study from our lab https://t.…

RT @CreekLab: From a phenotypic screen hit to mode of action- metabolomics and lipidomics bridge the gap. New study from our lab https://t.…

From a phenotypic screen hit to mode of action- metabolomics and lipidomics bridge the gap. New study from our lab https://t.co/vqxhJK4ZtY

RT @BioProteomics: Metabolomics News: Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti... https:/…

Metabolomics News: Metabolomics and lipidomics reveal perturbation of sphingolipid metabolism by a novel anti... https://t.co/TIuGCpofGs